apoplex medical technologies at the Masterclass 2019 in London

from 29 to 30 March 2019



Come and visit us!



read more!

apoplex medical technologies at the ESOC 2019 in Milan

from 22 to 24 May 2018



We are looking forward to your visit!

Read more!

Review 2018

We proudly point out that our service SRAclinic® is already used in more than 121 hospitals for the detection of paroxysmal atrial fibrillation.

In 2018 72.094 patients were examined, 10.540 patients were detected with atrial fibrillation by our automated algorithm. A risk was found in 16.446 patients.

New poster presentation as part of the UK Stroke Forum

New early atrial fibrillation (AF) detection by an automated remote monitoring system on hyperacute stroke unit (HASU)


Click here for the poster!

Dräger and apoplex medical technologies at the ÖGSF in Innsbruck from January 18 to 19, 2019

Visit us at our booth!

read more!

Leuag AG and apoplex medical technologies
at the Swiss Sroke Society Meeting in Zürich.

Come and visit us!

read more!

apoplex medical technologies at the UK Stroke Forum in Telford

Come and visit us!

read more!

ESC Congress Munich

From 25 to 29 August 2018

On site we inform visitors at the Pfizer/BMS Alliance booth - Exhibition 2 at stand number D200 about the stroke risk analysis (SRA®).

We look forward to your visit and interesting discussions!

read more!

New sales partner in Switzerland

For the exclusive distribution in Switzerland apoplex medical technologies could win Leuag AG. The medical technology specialist offers technically competent and efficient sales services for high-quality products for medicine and science and thus optimal conditions for synergies in the field of patient monitoring and cardiology. We are looking forward to a successful cooperation!

Read more!

Together against Stroke!



apoplex medical technologies participates in Evina Spain SL

Evina Spain markets the SRA analysis method exclusively in Spain. The aim is to integrate SRA as an integral part of stroke prevention. Within the scope of this project, a multicenter study was conducted in which SRA found twice as many AF patients as in the current practice with ECG telemetry monitoring, and 3 times faster. At the ESOC 2018 in Gothenburg, Prof. Davalos presented the study results to a specialist audience. The aim of this study is to establish a reimbursement for SRA in the Spanish health care system that would be unique in Europe and thus a good example of best practice.

Read more!

apoplex medical technologies at the ESOC 2018 in Gothenburg

from 16 to 18 May 2018



We are looking forward to your visit!

Read more!

ANIM 2018 in Würzburg.

From 08 to 10 February 2018

On site, apoplex medical technologies will inform visitors about the possibilities of using SRA.

We look forward to your visit!

Review 2017

e proudly point out that our service SRAclinic® is already used in more than 80 hospitals for the detection of paroxysmal pre-slurries (pVHF).

In 2017 61.589 patients were examined, 9.728 patients were detected by our automated algorithm pVHF. In 14.919 patients, a risk was identified for VHF.

Congresses in November 2017

In November 2017, we are presenting ourselves together with partners in the countries of Italy and Brazil.

In Italy we are on November 3rd on the III ° CONVEGNO NEUROVASCOLARE DEL GARDA. In Brazil from November 3rd - 5th at the 72nd Brazilian Congress of Cardiology 2017.

New homepage from October 2017

Since October 2017, we are presenting ourselves with a new Internet presence!

All information about the company and the stroke risk analysis are presented, informative and presented in a new design.

DGN 2017 in Leipzig with apoplex medical technologies from September 20 to 23, 2017

90th Congress of the German Society of Neurology

On site, apoplex medical technologies, together with the company Nihon Kohden, has informed visitors about the stroke risk analysis (SRA®).